Mehiläinen Group Acquires Aleris Group to Expand Specialist Healthcare

Mehiläinen Group is set to acquire Aleris Group from funds advised by Triton Partners, further consolidating its position as a leading specialist healthcare provider in Scandinavia. The deal, which remains subject to customary regulatory approvals, involves the transfer of Aleris’s full ownership The deal was announced on May 18, 2026.

Since Triton Partners acquired Aleris in 2019, the healthcare provider has undergone significant transformation. Aleris operates approximately 100 clinics across Sweden, Norway, and Denmark, employing around 5,300 healthcare professionals and serving roughly 3.8 million patient visits annually. Under Triton’s stewardship, Aleris has focused on improving clinical outcomes, reducing waiting times, and expanding its specialist care portfolio through divestments of non-core activities and bolt-on acquisitions in mental health, orthopedics, and hospital-at-home services.

Mehiläinen Group, a well-established private healthcare and social care provider, operates in nine European countries with over 55,000 employees and more than 1,450 locations. The acquisition of Aleris will expand Mehiläinen’s workforce to approximately 60,000 professionals and increase its annual patient visits to over 6 million. Mehiläinen’s CEO, Janne-Olli Järvenpää, highlighted the strategic fit, stating that both companies share a vision of outpatient-oriented, digitally powered, and patient-centered healthcare.

The combined entity aims to leverage synergies by cross-selling specialist services, expanding mental health and orthopedic offerings, and integrating digital platforms such as Aleris’s MyAleris patient portal with Mehiläinen’s digital capabilities. Operational efficiencies are expected through consolidation of administrative functions, procurement, and clinical best practices. This integration is designed to modernize care delivery and improve patient experience across the Scandinavian markets.

Founded in 1997 and headquartered in Stockholm, Aleris has established itself as a trusted complement to publicly funded healthcare systems in Scandinavia. Triton Partners, a European mid-market investor with a focus on healthcare, business services, and industrial technology, has overseen Aleris’s growth and quality improvements over seven years. Jan Pomoell, Partner and Head of Healthcare at Triton, praised the management and staff for their dedication in transforming Aleris into a focused specialist healthcare platform.

Mehiläinen’s acquisition of Aleris comes amid increasing consolidation in the healthcare sector, driven by the need for scale, digital innovation, and enhanced patient outcomes. The combined group will face integration challenges, including aligning organizational cultures, merging IT systems, and navigating regulatory approvals across multiple countries. Retaining key clinical talent will also be critical to maintaining service quality during the transition.

Once completed, the deal will position Mehiläinen as a dominant player in specialist healthcare across Scandinavia, with a broader service portfolio and enhanced digital health offerings. Both companies emphasize their commitment to improving healthcare quality and accessibility for patients in the region.